The NDUFS2 gene helps your mitochondria, the energy centers inside cells, make the energy your body needs each day. The protein made by this gene helps your cells turn food and oxygen into usable energy, especially in the brain, muscles, and heart. If the NDUFS2 gene does not work properly, energy production can drop and lead to a mitochondrial condition, often Leigh syndrome. People with harmful variants may have developmental delay, low muscle tone, movement problems, seizures, or breathing difficulties. NDUFS2 is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
NDUFS2Gene function
What if the gene works
The NDUFS2 gene helps mitochondria, your cells' energy centers, make energy through complex I, a key step in cell energy production. This supports steady energy supply, especially in organs with high energy needs like the brain, muscles, and heart.
Risk
What if the gene does not work
Variants in the NDUFS2 gene can reduce mitochondrial energy production, most often causing complex I deficiency with brain problems such as Leigh syndrome. Milder to more severe variants can change symptom onset and severity.
Treatment
What does that mean for your treatment
At present, no NDUFS2-specific treatment or drug selection approach is established for people with a pathogenic or loss-of-function variant in the NDUFS2 gene.
Conditions associated with NDUFS2
Gene function
What if the gene works
Your cells need a steady energy supply to power muscles, nerves, and organs. The NDUFS2 gene helps mitochondria, the parts of cells that make usable energy, carry out one of their main energy-making steps. This process is central to how the NDUFS2 gene helps cells make energy in the mitochondria.
NDUFS2 helps a large mitochondrial protein team move small charged particles called electrons along the cell's energy chain. This lets energy from food enter the pathway that powers ATP production.
Its protein helps pass that energy to coenzyme Q, a small carrier molecule inside mitochondria. This handoff keeps the energy-making sequence moving in the right direction.
As this step runs, the mitochondrial system builds a stored electrical charge across an inner membrane, the barrier inside mitochondria. Your cells use that charge to make ATP, the main energy molecule for everyday work.
This steady energy pathway supports tissues that work hard all day, including the brain, heart, and muscles. It helps cells keep up with routine tasks such as signaling, pumping, and movement.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In how NDUFS2 gene variants affect protein function, the main change is reduced activity of mitochondrial complex I, a key energy making step in cells. Some variants alter the protein’s shape or stability, while more disruptive variants can block complex I assembly almost completely. This creates a spectrum from partial loss of activity to near absence of function. In people with NDUFS2-related disease, greater loss of function often links to earlier onset and more severe features.
How variants are linked to conditions
Pathogenic variants in the NDUFS2 gene are linked to mitochondrial complex I deficiency, a rare inherited condition that often presents as Leigh syndrome. A confirmed pathogenic variant in the NDUFS2 gene can establish the diagnosis, and some people also have hypertrophic cardiomyopathy or other early-onset neurologic features. The NDUFS2 gene variants linked to Leigh syndrome usually cause symptoms in infancy or early childhood, although the exact pattern and severity can differ.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal part of human biology across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NDUFS2, there is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce genetic risk. When someone has disease-causing changes in both copies of NDUFS2, the chance of developing the related mitochondrial condition is mainly determined by those gene changes, while illness or other body stress can affect how severe symptoms become.
Inheritance of NDUFS2 variants
NDUFS2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one NDUFS2 variant from each parent, and the parents are typically healthy carriers. When both parents carry a variant in the NDUFS2 gene, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child with neither variant. NDUFS2 inheritance affects sons and daughters equally.
What does my NDUFS2 result mean for my family?
For NDUFS2, the main family implication is usually a recessive pattern, which means close relatives may carry the same gene change without having symptoms. Brothers and sisters of an affected child may also be affected or be carriers, and parents are often carriers. Other relatives, such as aunts, uncles, and cousins, may also carry the change in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NDUFS2 gene, a lab can test DNA from a blood sample or saliva. This kind of NDUFS2 genetic testing reads the gene’s code and may be done as part of a mitochondrial disease panel, exome sequencing, or genome sequencing.
When should I consider getting a genetic test?
Consider testing the NDUFS2 gene if there are signs of a condition that affects how the body makes energy, such as developmental delay, low muscle tone, seizures, movement problems, or repeated high lactate on blood tests, especially in infancy or childhood. Testing may also help if a close family member has a confirmed NDUFS2 change.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, although how much they reveal depends on the condition and the specific type of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems less helpful for another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug. These differences are common and can influence both how well a medicine works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect the response to medications. It examines links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes help shape how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment choices. If you want to learn more about this topic, more detail is available in the LearnHub.
Drugs influenced by the NDUFS2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about side effects, a new medicine, or how treatment fits with your health history, talk with your doctor or pharmacist.
History
Research on the NDUFS2 gene grew out of efforts to understand mitochondrial disease and the first enzyme complex in the cell’s energy chain, known as complex I. Initially studied through the biochemistry of complex I, NDUFS2 was later mapped and recognized as one of its nuclear genes. From these first observations, research expanded steadily as scientists linked changes in this gene to some cases of inherited complex I deficiency. Its history became part of a broader shift in medicine, where unexplained childhood neurologic and metabolic illnesses were increasingly traced to specific genes. As medical science evolved, so did understanding of this gene. Today, NDUFS2 is mainly known within mitochondrial medicine rather than through a public or cultural milestone.